Pfizer announces availability of CIBINQO®▼ (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis in Ireland 3 years ago
Merck and InnoCore Pharmaceuticals to improve patient compliance with new drug delivery technology 7 years ago